Aug 3 • 47M

#2: Dr. Manish Agrawal - Building Clinical Infrastructure for Psychedelic Medicine

Open in playerListen on);

Appears in this episode

Zach Haigney
The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance.
Episode details

Today I am speaking with Dr. Manish Agrawal.

Manish is the founder and CEO of Sunstone Therapies and co-director of clinical research at Aquilino Cancer Center in Rockville, Maryland.

Manish studied engineering at Auburn University and graduated from the University of Alabama School of Medicine. He did his medical residency at Georgetown University, where he also earned a master’s in Philosophy. After Georgetown, he did a fellowship at the National Institutes of Health.

He then went on to a more than 20-year career as an oncologist.

In 2017, Manish met Roland Griffiths from Johns Hopkins University, and his interest in psychedelic research was piqued, which led to the founding of Sunstone Therapies. 

Sunstone serves as an independent research site that carries out clinical trials for psychedelic drug developers like MAPS, Usona, and Compass Pathways, as well as their own investigator-initiated trials. They also train therapists. 

In this episode, we discuss:

  • Manish’s career as an oncologist and researcher;

  • His time at the National Institutes of Health (NIH);

  • The role his philosophy training has played in his life as a physician;

  • The origin story of Sunstone Therapies;

  • The similarities between delivering cancer treatment and the delivering psychedelic medicine; and 

  • Preparing for FDA approval.

Listen to the episode on Substack, Spotify, Google, or Apple.